ROYALTY PHARMA PLC: Diferență între versiuni

Pagina dedicata companiei ROYALTY PHARMA PLC listata cu simbolul US.RPRX

Descriere companie

Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.

Ultimele stiri despre ROYALTY PHARMA PLC (US.RPRX)

• Warren Buffett intensifica mizele Occidental si Apple, abandoneaza Verizon - 16 august 2022
• ROYALTY PHARMA PLC